{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T12:37:24Z","timestamp":1771331844165,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:00:00Z","timestamp":1769212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Guangzhou Basic and Applied Basic Research Foundation","award":["202201011030"],"award-info":[{"award-number":["202201011030"]}]},{"name":"Ganzhou Science and Technology Program","award":["2023NS227010 and 2023LNS26879"],"award-info":[{"award-number":["2023NS227010 and 2023LNS26879"]}]},{"name":"Foundation of Department of Finance of Guangdong Province","award":["KS0120220269"],"award-info":[{"award-number":["KS0120220269"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"DOI":"10.1186\/s12894-026-02055-y","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T10:16:09Z","timestamp":1769249769000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and external validation of nomograms for predicting prostate cancer and clinically significant prostate cancer in patients with PSA between 4 and 20 ng\/mL"],"prefix":"10.1186","volume":"26","author":[{"given":"Kunlin","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chujin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiye","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duanyao","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinglin","family":"Ba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanzhong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,24]]},"reference":[{"key":"2055_CR1","doi-asserted-by":"publisher","unstructured":"Bray F, Laversanne M, Sung H et al Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin Published Online April. 2024;4. https:\/\/doi.org\/10.3322\/caac.21834.","DOI":"10.3322\/caac.21834"},{"issue":"3","key":"2055_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"2055_CR3","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1007\/s12325-018-0766-1","volume":"35","author":"SWD Merriel","year":"2018","unstructured":"Merriel SWD, Funston G, Hamilton W. Prostate cancer in primary care. Adv Ther. 2018;35(9):1285\u201394. https:\/\/doi.org\/10.1007\/s12325-018-0766-1.","journal-title":"Adv Ther"},{"issue":"1","key":"2055_CR4","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/his.13712","volume":"74","author":"A Matoso","year":"2019","unstructured":"Matoso A, Epstein JI. Defining clinically significant prostate cancer on the basis of pathological findings. Histopathology. 2019;74(1):135\u201345. https:\/\/doi.org\/10.1111\/his.13712.","journal-title":"Histopathology"},{"issue":"4","key":"2055_CR5","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3322\/caac.20026","volume":"59","author":"OW Brawley","year":"2009","unstructured":"Brawley OW, Ankerst DP, Thompson IM. Screening for prostate cancer. CA Cancer J Clin. 2009;59(4):264\u201373. https:\/\/doi.org\/10.3322\/caac.20026.","journal-title":"CA Cancer J Clin"},{"key":"2055_CR6","doi-asserted-by":"publisher","first-page":"o1714","DOI":"10.1136\/bmj.o1714","volume":"378","author":"CM Booth","year":"2022","unstructured":"Booth CM, Chinegwundoh F, Allen S, Van Poppel H. Diagnosing prostate cancer at a curable stage means providing PSA tests to asymptomatic patients. BMJ. 2022;378:o1714. https:\/\/doi.org\/10.1136\/bmj.o1714.","journal-title":"BMJ"},{"issue":"23","key":"2055_CR7","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1056\/NEJMoa2209454","volume":"387","author":"J Hugosson","year":"2022","unstructured":"Hugosson J, M\u00e5nsson M, Wallstr\u00f6m J, et al. Prostate cancer screening with PSA and MRI followed by targeted biopsy only. N Engl J Med. 2022;387(23):2126\u201337. https:\/\/doi.org\/10.1056\/NEJMoa2209454.","journal-title":"N Engl J Med"},{"issue":"16","key":"2055_CR8","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1002\/pros.24078","volume":"80","author":"N Omri","year":"2020","unstructured":"Omri N, Kamil M, Alexander K, et al. Association between PSA density and pathologically significant prostate cancer: the impact of prostate volume. Prostate. 2020;80(16):1444\u20139. https:\/\/doi.org\/10.1002\/pros.24078.","journal-title":"Prostate"},{"key":"2055_CR9","doi-asserted-by":"publisher","first-page":"693684","DOI":"10.3389\/fonc.2021.693684","volume":"11","author":"SM Bruno","year":"2021","unstructured":"Bruno SM, Falagario UG, d\u2019Altilia N, et al. PSA density help to identify patients with elevated PSA due to prostate cancer rather than intraprostatic inflammation: A prospective single center study. Front Oncol. 2021;11:693684. https:\/\/doi.org\/10.3389\/fonc.2021.693684.","journal-title":"Front Oncol"},{"key":"2055_CR10","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.urology.2017.04.015","volume":"105","author":"JS Jue","year":"2017","unstructured":"Jue JS, Barboza MP, Prakash NS, et al. Re-examining prostate-specific antigen (PSA) density: defining the optimal PSA range and patients for using PSA density to predict prostate cancer using extended template biopsy. Urology. 2017;105:123\u20138. https:\/\/doi.org\/10.1016\/j.urology.2017.04.015.","journal-title":"Urology"},{"key":"2055_CR11","doi-asserted-by":"publisher","unstructured":"TurkbeyB,Rosenkrantz AB, Haider MA, et al. Eur Urol. 2019;76(3):340\u201351. https:\/\/doi.org\/10.1016\/j.eururo.2019.02.033","DOI":"10.1016\/j.eururo.2019.02.033"},{"issue":"4","key":"2055_CR12","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.eururo.2019.10.024","volume":"77","author":"B Isra\u00ebl","year":"2020","unstructured":"Isra\u00ebl B, Leest M, van der, Sedelaar M, Padhani AR, Z\u00e1mecnik P, Barentsz JO. Multiparametric magnetic resonance imaging for the detection of clinically significant prostate cancer: what urologists need to Know. Part 2: interpretation. Eur Urol. 2020;77(4):469\u201380. https:\/\/doi.org\/10.1016\/j.eururo.2019.10.024.","journal-title":"Eur Urol"},{"issue":"2","key":"2055_CR13","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41391-018-0107-0","volume":"22","author":"RL Sherrer","year":"2019","unstructured":"Sherrer RL, Glaser ZA, Gordetsky JB, Nix JW, Porter KK, Rais-Bahrami S. Comparison of biparametric MRI to full multiparametric MRI for detection of clinically significant prostate cancer. Prostate Cancer Prostatic Dis. 2019;22(2):331\u20136. https:\/\/doi.org\/10.1038\/s41391-018-0107-0.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"2055_CR14","doi-asserted-by":"publisher","first-page":"1020317","DOI":"10.3389\/fonc.2022.1020317","volume":"12","author":"Y Lu","year":"2022","unstructured":"Lu Y, Li B, Huang H, et al. Biparametric MRI-based radiomics classifiers for the detection of prostate cancer in patients with PSA serum levels of 4\u223c10 ng\/mL. Front Oncol. 2022;12:1020317. https:\/\/doi.org\/10.3389\/fonc.2022.1020317.","journal-title":"Front Oncol"},{"issue":"4","key":"2055_CR15","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3322\/caac.21333","volume":"66","author":"B Turkbey","year":"2016","unstructured":"Turkbey B, Brown AM, Sankineni S, Wood BJ, Pinto PA, Choyke PL. Multiparametric prostate magnetic resonance imaging in the evaluation of prostate cancer. CA Cancer J Clin. 2016;66(4):326\u201336. https:\/\/doi.org\/10.3322\/caac.21333.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"2055_CR16","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.4103\/jcrt.JCRT_1313_20","volume":"18","author":"M Mahajan","year":"2022","unstructured":"Mahajan M, Gupta V, Gupta P, Sharma P, Abrol D. Evaluation of clinically significant prostate cancer using biparametric magnetic resonance imaging: an evolving concept. J Cancer Res Ther. 2022;18(6):1640\u20135. https:\/\/doi.org\/10.4103\/jcrt.JCRT_1313_20.","journal-title":"J Cancer Res Ther"},{"issue":"3","key":"2055_CR17","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1148\/radiol.2019181705","volume":"292","author":"A Panda","year":"2019","unstructured":"Panda A, Obmann VC, Lo WC, et al. MR fingerprinting and ADC mapping for characterization of lesions in the transition zone of the prostate gland. Radiology. 2019;292(3):685\u201394. https:\/\/doi.org\/10.1148\/radiol.2019181705.","journal-title":"Radiology"},{"issue":"7","key":"2055_CR18","doi-asserted-by":"publisher","first-page":"e445","DOI":"10.1016\/S2589-7500(21)00082-0","volume":"3","author":"A Hiremath","year":"2021","unstructured":"Hiremath A, Shiradkar R, Fu P, et al. An integrated nomogram combining deep learning, prostate Imaging-Reporting and data system (PI-RADS) scoring, and clinical variables for identification of clinically significant prostate cancer on biparametric MRI: a retrospective multicentre study. Lancet Digit Health. 2021;3(7):e445\u201354. https:\/\/doi.org\/10.1016\/S2589-7500(21)00082-0.","journal-title":"Lancet Digit Health"},{"key":"2055_CR19","doi-asserted-by":"publisher","first-page":"7722","DOI":"10.1038\/s41598-020-64693-y","volume":"10","author":"S Alqahtani","year":"2020","unstructured":"Alqahtani S, Wei C, Zhang Y, et al. Prediction of prostate cancer Gleason score upgrading from biopsy to radical prostatectomy using pre-biopsy multiparametric MRI PIRADS scoring system. Sci Rep. 2020;10:7722. https:\/\/doi.org\/10.1038\/s41598-020-64693-y.","journal-title":"Sci Rep"},{"key":"2055_CR20","doi-asserted-by":"publisher","DOI":"10.5281\/zenodo.6667655","author":"A Saha","year":"2022","unstructured":"Saha A, Twilt JJ, Bosma JS, et al. Artificial intelligence and radiologists at prostate cancer detection in MRI: the PI-CAI challenge (Study Protocol). Zenodo. 2022. https:\/\/doi.org\/10.5281\/zenodo.6667655.","journal-title":"Zenodo"},{"issue":"417","key":"2055_CR21","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1080\/01621459.1992.10475190","volume":"87","author":"J Fox","year":"1992","unstructured":"Fox J, Monette G. Generalized collinearity diagnostics. J Am Stat Assoc. 1992;87(417):178\u201383. https:\/\/doi.org\/10.1080\/01621459.1992.10475190.","journal-title":"J Am Stat Assoc"},{"issue":"10","key":"2055_CR22","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1056\/NEJMoa1910038","volume":"382","author":"M Ahdoot","year":"2020","unstructured":"Ahdoot M, Wilbur AR, Reese SE, et al. MRI-Targeted, Systematic, and combined biopsy for prostate cancer diagnosis. N Engl J Med. 2020;382(10):917\u201328. https:\/\/doi.org\/10.1056\/NEJMoa1910038.","journal-title":"N Engl J Med"},{"issue":"12","key":"2055_CR23","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.1007\/s00261-020-02547-x","volume":"45","author":"IG Schoots","year":"2020","unstructured":"Schoots IG, Padhani AR. Delivering clinical impacts of the MRI diagnostic pathway in prostate cancer diagnosis. Abdom Radiol N Y. 2020;45(12):4012\u201322. https:\/\/doi.org\/10.1007\/s00261-020-02547-x.","journal-title":"Abdom Radiol N Y"},{"key":"2055_CR24","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12880-023-01074-7","volume":"23","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wang L, Tang X, et al. Development and validation of a nomogram based on biparametric MRI PI-RADS v2.1 and clinical parameters to avoid unnecessary prostate biopsies. BMC Med Imaging. 2023;23:106. https:\/\/doi.org\/10.1186\/s12880-023-01074-7.","journal-title":"BMC Med Imaging"},{"issue":"8","key":"2055_CR25","doi-asserted-by":"publisher","first-page":"205846011666304","DOI":"10.1177\/2058460116663046","volume":"5","author":"KCD Thestrup","year":"2016","unstructured":"Thestrup KCD, Logager V, Baslev I, M\u00f8ller JM, Hansen RH, Thomsen HS. Biparametric versus multiparametric MRI in the diagnosis of prostate cancer. Acta Radiol Open. 2016;5(8):2058460116663046. https:\/\/doi.org\/10.1177\/2058460116663046.","journal-title":"Acta Radiol Open"},{"key":"2055_CR26","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s40644-023-00606-2","volume":"23","author":"B Hu","year":"2023","unstructured":"Hu B, Zhang H, Zhang Y, Jin Y. A nomogram based on biparametric magnetic resonance imaging for detection of clinically significant prostate cancer in biopsy-na\u00efve patients. Cancer Imaging. 2023;23:82. https:\/\/doi.org\/10.1186\/s40644-023-00606-2.","journal-title":"Cancer Imaging"},{"issue":"4","key":"2055_CR27","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1002\/jmri.27841","volume":"55","author":"MJ Kim","year":"2022","unstructured":"Kim MJ, Park SY. Biparametric magnetic resonance Imaging-Derived nomogram to detect clinically significant prostate cancer by targeted biopsy for index lesion. J Magn Reson Imaging. 2022;55(4):1226\u201333. https:\/\/doi.org\/10.1002\/jmri.27841.","journal-title":"J Magn Reson Imaging"},{"issue":"3","key":"2055_CR28","doi-asserted-by":"publisher","first-page":"E161","DOI":"10.5489\/cuaj.7380","volume":"16","author":"A Kinnaird","year":"2022","unstructured":"Kinnaird A, Brisbane W, Kwan L, et al. A prostate cancer risk calculator: use of clinical and magnetic resonance imaging data to predict biopsy outcome in North American men. Can Urol Assoc J. 2022;16(3):E161\u20136. https:\/\/doi.org\/10.5489\/cuaj.7380.","journal-title":"Can Urol Assoc J"},{"issue":"3","key":"2055_CR29","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/s41391-023-00660-8","volume":"26","author":"MR Siddiqui","year":"2023","unstructured":"Siddiqui MR, Li EV, Kumar SKSR, et al. Optimizing detection of clinically significant prostate cancer through nomograms incorporating mri, clinical features, and advanced serum biomarkers in biopsy na\u00efve men. Prostate Cancer Prostatic Dis. 2023;26(3):588\u201395. https:\/\/doi.org\/10.1038\/s41391-023-00660-8.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"7","key":"2055_CR30","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.21037\/tau-22-832","volume":"12","author":"C Cheng","year":"2023","unstructured":"Cheng C, Liu J, Yi X, et al. Prediction of clinically significant prostate cancer using a novel 68Ga-PSMA PET-CT and multiparametric MRI-based model. Transl Androl Urol. 2023;12(7):1115\u201326. https:\/\/doi.org\/10.21037\/tau-22-832.","journal-title":"Transl Androl Urol"},{"issue":"12","key":"2055_CR31","doi-asserted-by":"publisher","first-page":"7909","DOI":"10.1007\/s00330-024-10818-0","volume":"34","author":"A Schrader","year":"2024","unstructured":"Schrader A, Netzer N, Hielscher T, et al. Prostate cancer risk assessment and avoidance of prostate biopsies using fully automatic deep learning in prostate MRI: comparison to PI-RADS and integration with clinical data in nomograms. Eur Radiol. 2024;34(12):7909\u201320. https:\/\/doi.org\/10.1007\/s00330-024-10818-0.","journal-title":"Eur Radiol"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-026-02055-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-026-02055-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-026-02055-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T11:56:15Z","timestamp":1771329375000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12894-026-02055-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,24]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2055"],"URL":"https:\/\/doi.org\/10.1186\/s12894-026-02055-y","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,24]]},"assertion":[{"value":"15 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study involving patients was reviewed and approved by the Ethics Committee of Guangdong Provincial People\u2019s Hospital (KY-Z-2022-349-03) and was conducted in accordance with the Declaration of Helsinki. As a retrospective study, the requirement for written informed consent was waived by the committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"49"}}